Zobrazeno 1 - 10
of 28
pro vyhledávání: '"S L, Cochi"'
Publikováno v:
Pediatric Clinics of North America. 47:287-308
Poliomyelitis prevention in the United States has relied virtually exclusively on OPV during the past 30 years. Starting in 1997, a major change in the poliomyelitis vaccination policy occurred, facilitated by substantial progress toward worldwide po
Publikováno v:
Developments in biologicals. 105
One of the challenges of the polio eradication initiative over the next few years will be the formulation of an optimal strategy for stopping poliovirus vaccination after global certification of polio eradication has been accomplished. This strategy
Publikováno v:
Bulletin of the World Health Organization. 78(3)
Disease eradication as a public health strategy was discussed at international meetings in 1997 and 1998. In this article, the ongoing poliomyelitis eradication initiative is examined using the criteria for evaluating candidate diseases for eradicati
Publikováno v:
Pediatric clinics of North America. 47(2)
Poliomyelitis prevention in the United States has relied virtually exclusively on OPV during the past 30 years. Starting in 1997, a major change in the poliomyelitis vaccination policy occurred, facilitated by substantial progress toward worldwide po
Autor:
S L, Cochi, W A, Orenstein
Publikováno v:
The Pediatric infectious disease journal. 14(4)
Autor:
P M, Strebel, A, Aubert-Combiescu, N, Ion-Nedelcu, S, Biberi-Moroeanu, M, Combiescu, R W, Sutter, O M, Kew, M A, Pallansch, P A, Patriarca, S L, Cochi
Publikováno v:
American journal of epidemiology. 140(12)
Although poliomyelitis due to wild-virus infection has virtually disappeared from Romania, with no cases having been documented between 1984 and 1989, vaccine-associated paralytic poliomyelitis has been reported at very high rates for over two decade
Publikováno v:
Pediatrics. 94(6 Pt 2)
Autor:
S L, Cochi
Publikováno v:
Pediatrics. 94(6 Pt 2)
Vaccination policies for preschool-age children, including those in child day care, have undergone frequent changes within the past several years in response to the development of new vaccines (DTaP, Hib conjugate vaccines), the changing epidemiology
Autor:
T A, Lieu, S L, Cochi, S B, Black, M E, Halloran, H R, Shinefield, S J, Holmes, M, Wharton, A E, Washington
Publikováno v:
JAMA. 271(5)
To evaluate the economic consequences of a routine varicella vaccination program that targets healthy children.Decision analysis was used to compare the costs, outcomes, and cost-effectiveness of a routine vaccination program with no intervention. Cl
Publikováno v:
JAMA. 269(2)
Effective Haemophilus influenzae type b (Hib) conjugate vaccines were first licensed for use in US children at least 18 months old in December 1987 and for infants at least 2 months old in October 1990. We evaluated trends in Hib disease associated w